|
Jan 8
|
Illumina (ILMN) Extends Partnership to Advance Cancer Test
|
|
Jan 5
|
Illumina expands collaboration with Janssen to advance molecular residual disease cancer test
|
|
Jan 4
|
Illumina to Announce Fourth Quarter and Full Year 2023 Financial Results on Thursday, February 8, 2024
|
|
Jan 4
|
The Alliance for Genomic Discovery welcomes Bristol Myers Squibb, GSK, and Novo Nordisk
|
|
Dec 21
|
Nucleus Genomics Wants To Make Personalized Health Care a Reality
|
|
Dec 19
|
Heard on the Street: Illumina Nears the End of Its Painful Grail Saga
|
|
Dec 19
|
S&P 500 Gains and Losses Today: Enphase's Cost Cutting Charges Up Solar Stocks
|
|
Dec 19
|
Illumina To Webcast Upcoming Investor Conference
|
|
Dec 19
|
FTC, DOJ finalize merger guidelines that could impede healthcare M&A
|
|
Dec 19
|
Carl Icahn to initiate proxy battle with Illumina — again
|
|
Dec 19
|
A Lesser-Known Application of Genomics: Reducing Cow Burp Intensity
|
|
Dec 19
|
The 2023 stock market rally isn't just about 7 stocks anymore
|
|
Dec 19
|
Grail CEO predicts ‘transformative’ 2024 amid Illumina split
|
|
Dec 19
|
Could the ‘trustbusters’ be making a comeback?
|
|
Dec 18
|
These Stocks Are Moving the Most Today: U.S. Steel, Apple, Adobe, SunPower, VF Corp, NIO, and More
|
|
Dec 18
|
Illumina Ends Its Controversial Grail Battle With A Divestiture; Shares Rise
|
|
Dec 18
|
US Steel & Nippon, Adobe, Illumina: Top M&A announcements
|
|
Dec 18
|
Illumina-Grail $8B Saga Ends After It Battles Regulators For 3 Years
|
|
Dec 18
|
Illumina Gives Up Fight With Regulators, Will Divest GRAIL
|
|
Dec 18
|
These Stocks Are Moving the Most Today
|